← Leaderboards
Dana M Brantley-Sieders
Vanderbilt University
$4,304,141
Attributed
$7,411,993
Total exposure
5
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.1M · FY2006–22$2M$1.5M$1M$500K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$7,411,993 · 5
By mechanism
R01$6,612,693 · 4
K01$799,300 · 1
Top collaborators
- Rebecca Sara Cook9 shared
- Craig Lewis Duvall9 shared
- Jin Chen7 shared
- Md Jashim Uddin1 shared
- Kasey C Vickers1 shared
Most similar at Vanderbilt University
Same institution · by research overlap
- Rebecca Sara Cook$4,266,124
- Md Jashim Uddin$728,003
- Eileen Shiuan$114,704
- Benjamin Christian Hacker$78,323
- Thomas A Werfel$1,074,749
Others in their field
Top investigators on “In Vivo”
- David Heimbrook · Leidos Biomedical Research, Inc.$371,850,582
- Leonard Freedman · Leidos Biomedical Research, Inc.$304,459,298
- Dennis R. Burton · Scripps Research Institute$212,708,174
- Mark S Klempner · Tufts Medical Center$128,021,180
- Florian Krammer · Icahn School Of Medicine At Mount Sinai$104,723,856
- David M. Margolis · University Of Texas Sw Med Ctr/Dallas$98,374,200
Research focus
In VivoTumorInvestigationCellsMalignant NeoplasmsMolecularNeoplasm MetastasisTumor GrowthNeoplastic CellSignal TransductionMalignant Breast NeoplasmMouse ModelBlood VesselsGrowthMammary NeoplasmsInhibitor/AntagonistSmall Interfering RnaAnimalsLigandsMediatingCessation Of LifeLinkMammary GlandLung
Grant awards (28)
NextGen RNAi Delivery to Breast Tumors for Selective mTORC2 Blockade$441,312
R01 · FY2022 · CA
NextGen RNAi Delivery to Breast Tumors for Selective mTORC2 Blockade$72,819
R01 · FY2022 · CA
In Situ Albumin Binding siRNAs for Triple Negative Breast Cancer Tumor Penetration and Molecularly Targeted Therapy$617,228
R01 · FY2021 · CA
NextGen RNAi Delivery to Breast Tumors for Selective mTORC2 Blockade$450,319
R01 · FY2021 · CA
NextGen RNAi Delivery to Breast Tumors for Selective mTORC2 Blockade$74,306
R01 · FY2021 · CA
NextGen RNAi Delivery to Breast Tumors for Selective mTORC2 Blockade$450,319
R01 · FY2020 · CA
NextGen RNAi Delivery to Breast Tumors for Selective mTORC2 Blockade$74,113
R01 · FY2020 · CA
NextGen RNAi Delivery to Breast Tumors for Selective mTORC2 Blockade$436,809
R01 · FY2019 · CA
ephrin-A1 in lipogenesis and breast cancer metastatic progression$46,888
R01 · FY2019 · CA
NextGen RNAi Delivery to Breast Tumors for Selective mTORC2 Blockade$464,569
R01 · FY2018 · CA
ephrin-A1 in lipogenesis and breast cancer metastatic progression$379,993
R01 · FY2018 · CA
ephrin-A1 in lipogenesis and breast cancer metastatic progression$379,993
R01 · FY2017 · CA
ephrin-A1 in lipogenesis and breast cancer metastatic progression$379,993
R01 · FY2016 · CA
ephrin-A1 in lipogenesis and breast cancer metastatic progression$189,380
R01 · FY2015 · CA
ephrin-A1 in lipogenesis and breast cancer metastatic progression$188,212
R01 · FY2015 · CA
EphA2 Receptor in Endothelial Cell-Mediated Tumor Progression$165,468
R01 · FY2015 · CA · contact PI
EphA2 Receptor in Endothelial Cell-Mediated Tumor Progression$158,232
R01 · FY2015 · CA · contact PI
ephrin-A1 in lipogenesis and breast cancer metastatic progression$377,592
R01 · FY2014 · CA
EphA2 Receptor in Endothelial Cell-Mediated Tumor Progression$313,989
R01 · FY2014 · CA · contact PI
EphA2 Receptor in Endothelial Cell-Mediated Tumor Progression$304,278
R01 · FY2013 · CA · contact PI
EphA2 Receptor in Endothelial Cell-Mediated Tumor Progression$323,700
R01 · FY2012 · CA · contact PI
EphA2 Receptor in Endothelial Cell-Mediated Tumor Progression$323,181
R01 · FY2011 · CA · contact PI
The role of EphA2 receptor signaling in host-tumor interactions$152,820
K01 · FY2010 · CA · contact PI
The role of EphA2 receptor signaling in host-tumor interactions$152,820
K01 · FY2009 · CA · contact PI
The role of EphA2 receptor signaling in host-tumor interactions$100,000
K01 · FY2009 · CA · contact PI
The role of EphA2 receptor signaling in host-tumor interactions$131,220
K01 · FY2008 · CA · contact PI
The role of EphA2 receptor signaling in host-tumor interactions$131,220
K01 · FY2007 · CA · contact PI
The role of EphA2 receptor signaling in host-tumor interactions$131,220
K01 · FY2006 · CA · contact PI